631 related articles for article (PubMed ID: 33549093)
1. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
[TBL] [Abstract][Full Text] [Related]
5. Does postoperative adjuvant transarterial chemoembolization benefit for all patients with hepatocellular carcinoma combined with microvascular invasion: a meta-analysis.
Wang L; Ke Q; Lin N; Zeng Y; Liu J
Scand J Gastroenterol; 2019 May; 54(5):528-537. PubMed ID: 31081401
[No Abstract] [Full Text] [Related]
6. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinoma.
Chen W; Ma T; Zhang J; Zhang X; Chen W; Shen Y; Bai X; Liang T
HPB (Oxford); 2020 Jun; 22(6):795-808. PubMed ID: 31980307
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant transarterial chemoembolization for multinodular hepatocellular carcinoma within the Barcelona Clinic Liver Cancer early stage and microvascular invasion.
Wang H; Du PC; Wu MC; Cong WM
Hepatobiliary Surg Nutr; 2018 Dec; 7(6):418-428. PubMed ID: 30652086
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
9. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study.
Xiang C; Shen X; Zeng X; Zhang Y; Ma Z; Zhang G; Song X; Huang T; Yang J
Int J Surg; 2024 Jan; 110(1):315-323. PubMed ID: 37812183
[TBL] [Abstract][Full Text] [Related]
10. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion.
Wang L; Wang W; Yao X; Rong W; Wu F; Chen B; Liu M; Lin S; Liu Y; Wu J
Oncotarget; 2017 Oct; 8(45):79971-79981. PubMed ID: 29108379
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Shen A; Liu M; Zheng D; Chen Q; Wu Z
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
[TBL] [Abstract][Full Text] [Related]
14. Postoperative adjuvant transcatheter arterial chemoembolization should be considered selectively in patients who have hepatocellular carcinoma with microvascular invasion.
Wang YY; Wang LJ; Xu D; Liu M; Wang HW; Wang K; Zhu X; Xing BC
HPB (Oxford); 2019 Apr; 21(4):425-433. PubMed ID: 30249510
[TBL] [Abstract][Full Text] [Related]
15. Survival benefits from adjuvant transcatheter arterial chemoembolization in patients undergoing liver resection for hepatocellular carcinoma: a systematic review and meta-analysis.
Liang L; Li C; Diao YK; Jia HD; Xing H; Pawlik TM; Lau WY; Shen F; Huang DS; Zhang CW; Yang T
Therap Adv Gastroenterol; 2020; 13():1756284820977693. PubMed ID: 33329759
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
[TBL] [Abstract][Full Text] [Related]
17. Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.
Wang L; Chen B; Li Z; Yao X; Liu M; Rong W; Wu F; Lin S; Liu Y; Zheng Y; Li Y; Wang W; Wu J
Onco Targets Ther; 2019; 12():1237-1247. PubMed ID: 30863091
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of sequential TACE on primary hepatocellular carcinoma with microvascular invasion after radical resection: a systematic review and meta-analysis.
Mo A; Lin B; Chen D
World J Surg Oncol; 2023 Sep; 21(1):277. PubMed ID: 37667375
[TBL] [Abstract][Full Text] [Related]
19. Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma.
Peng Z; Chen S; Xiao H; Wang Y; Li J; Mei J; Chen Z; Zhou Q; Feng S; Chen M; Qian G; Peng S; Kuang M
Radiology; 2019 Jul; 292(1):237-247. PubMed ID: 31135299
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit from adjuvant TACE combined with Lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy.
Liang L; Xu ZD; Lu WF; Du CF; Gao ZY; Huang XK; Wang KD; Ye TW; Dai MG; Liu SY; Shen GL; Liu JW; Zhang CW; Huang DS
Asian J Surg; 2024 May; ():. PubMed ID: 38724372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]